Hui Guo

2.0k total citations
75 papers, 1.1k citations indexed

About

Hui Guo is a scholar working on Molecular Biology, Cancer Research and Immunology. According to data from OpenAlex, Hui Guo has authored 75 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 37 papers in Molecular Biology, 18 papers in Cancer Research and 16 papers in Immunology. Recurrent topics in Hui Guo's work include Lymphoma Diagnosis and Treatment (12 papers), Chronic Lymphocytic Leukemia Research (10 papers) and Cancer, Hypoxia, and Metabolism (7 papers). Hui Guo is often cited by papers focused on Lymphoma Diagnosis and Treatment (12 papers), Chronic Lymphocytic Leukemia Research (10 papers) and Cancer, Hypoxia, and Metabolism (7 papers). Hui Guo collaborates with scholars based in China, United States and Macao. Hui Guo's co-authors include Xinyi Wu, Juan Shi, Hang Sun, Dexian Zheng, Jianping Gong, Qi Liu, Michael Wang, Qiji Liu, Yehua Ge and Min Liu and has published in prestigious journals such as Journal of Clinical Investigation, Nature Communications and Journal of Clinical Oncology.

In The Last Decade

Hui Guo

63 papers receiving 1.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Hui Guo China 19 554 217 204 151 107 75 1.1k
Arezoo Gowhari Shabgah Iran 21 405 0.7× 152 0.7× 547 2.7× 385 2.5× 101 0.9× 44 1.3k
Duen-Yi Huang Taiwan 20 565 1.0× 89 0.4× 344 1.7× 170 1.1× 38 0.4× 41 1.1k
Javier Megías Spain 19 509 0.9× 110 0.5× 297 1.5× 72 0.5× 53 0.5× 46 1.1k
Xueming Zhang China 20 633 1.1× 168 0.8× 103 0.5× 55 0.4× 44 0.4× 92 1.3k
Vincenzo Flati Italy 22 595 1.1× 128 0.6× 268 1.3× 227 1.5× 58 0.5× 54 1.4k
Chen Shao China 20 545 1.0× 153 0.7× 230 1.1× 57 0.4× 35 0.3× 68 1.1k
Dexi Zhou China 14 430 0.8× 158 0.7× 527 2.6× 164 1.1× 58 0.5× 20 1.1k
Xianghong Xu China 19 753 1.4× 216 1.0× 586 2.9× 130 0.9× 40 0.4× 55 2.0k

Countries citing papers authored by Hui Guo

Since Specialization
Citations

This map shows the geographic impact of Hui Guo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hui Guo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hui Guo more than expected).

Fields of papers citing papers by Hui Guo

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hui Guo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hui Guo. The network helps show where Hui Guo may publish in the future.

Co-authorship network of co-authors of Hui Guo

This figure shows the co-authorship network connecting the top 25 collaborators of Hui Guo. A scholar is included among the top collaborators of Hui Guo based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hui Guo. Hui Guo is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Wang, Yifan, Yifan Wang, Jun Zhao, et al.. (2025). Reviewing the IDH1 Mutation‐Mediated Mechanism of Drug Resistance and Revisiting Its Overcoming Strategies. Chemical Biology & Drug Design. 105(4). e70102–e70102.
3.
Han, Fang, et al.. (2025). Inhibition of LRRK2 Ameliorates Aspergillus fumigatus Keratitis by Regulating STING Signaling Pathways. Investigative Ophthalmology & Visual Science. 66(2). 13–13.
4.
Xu, Yuwei, Hui Guo, Ying Du, et al.. (2025). Microbiota metabolite taurodeoxycholic acid maintains intestinal tissue residency of innate lymphoid cells via engagement with P2Y10 receptor. Science Advances. 11(34). eadt9645–eadt9645.
5.
Wang, Xiaorui, et al.. (2025). Machine learning-based QSAR and structure-based virtual screening guided discovery of novel mIDH1 inhibitors from natural products. Journal of Computer-Aided Molecular Design. 39(1). 44–44.
6.
Wang, Yifan, Yifan Wang, Fan Wang, et al.. (2024). 3D-QSAR, Scaffold Hopping, Virtual Screening, and Molecular Dynamics Simulations of Pyridin-2-one as mIDH1 Inhibitors. International Journal of Molecular Sciences. 25(13). 7434–7434. 2 indexed citations
7.
Zhang, Weitong, Yifan Wang, Xiaorui Wang, et al.. (2024). Identification of mIDH1 R132C/S280F Inhibitors from Natural Products by Integrated Molecular Docking, Pharmacophore Modeling and Molecular Dynamics Simulations. Pharmaceuticals. 17(3). 336–336. 3 indexed citations
8.
Qiu, Yunping, Jin Zhou, Wei Shan, et al.. (2024). Association between short-term ozone exposure and allergic conjunctivitis in China: A multi-city case-crossover study. Environmental Pollution. 358. 124506–124506.
9.
Liu, Wenhui, Wenzhe Zhang, Kaiyue Li, et al.. (2024). TRPV4 antagonist suppresses retinal ganglion cell apoptosis by regulating the activation of CaMKII and TNF-α expression in a chronic ocular hypertension rat model. International Immunopharmacology. 130. 111811–111811. 3 indexed citations
10.
Ruan, Zengliang, Tao Zhang, Jian Wang, et al.. (2024). Daily gaseous air pollution and pediatric conjunctivitis: A case-crossover study across ten cities in China's southeastern coastal region. Journal of Hazardous Materials. 480. 136032–136032. 1 indexed citations
11.
Zhang, Huiru, Hui Guo, Yan Jia, et al.. (2023). Ursolic acid ameliorates DNCB-induced atopic dermatitis-like symptoms in mice by regulating TLR4/NF-κB and Nrf2/HO-1 signaling pathways. International Immunopharmacology. 118. 110079–110079. 24 indexed citations
12.
Guo, Hui, Zhimin Jiang, Xiaoxiao Zhu, et al.. (2023). Noncoding RNA circBtnl1 suppresses self‐renewal of intestinal stem cells via disruption of Atf4 mRNA stability. The EMBO Journal. 42(6). e112039–e112039. 15 indexed citations
13.
14.
Shen, Lin, et al.. (2021). Long-Term Observation and Sequencing Analysis of SKPs-Derived Corneal Endothelial Cell-Like Cells for Treating Corneal Endothelial Dysfunction. Cell Transplantation. 30. 4211075686–4211075686. 5 indexed citations
15.
16.
Guo, Hui, Dongfeng Zeng, Hui Zhang, et al.. (2018). Dual inhibition of PI3K signaling and histone deacetylation halts proliferation and induces lethality in mantle cell lymphoma. Oncogene. 38(11). 1802–1814. 20 indexed citations
17.
Huang, Shengjian, Changying Jiang, Hui Guo, et al.. (2017). Resistance Mechanisms Underlying Venetoclax Resistance in Mantle Cell Lymphoma. Blood. 130. 2749–2749. 8 indexed citations
18.
Guo, Hui, Taylor Bell, Shengjian Huang, et al.. (2016). CUDC-907: An Oral HDAC/PI3K Dual Inhibitor with Strong Preclinical Efficacy in MCL Model. Blood. 128(22). 4183–4183. 2 indexed citations
19.
Gao, Nan, Ashok Kumar, Hui Guo, et al.. (2011). Topical Flagellin-Mediated Innate Defense against Candida albicans Keratitis. Investigative Ophthalmology & Visual Science. 52(6). 3074–3074. 36 indexed citations
20.
Li, Bo, Xiang Li, Yingxin Li, et al.. (2010). The effects of hepatitis C virus non-structural protein 3 on cell growth mediated by extracellular signal-related kinase cascades in human hepatocytes in vitro.. PubMed. 26(2). 273–9. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Arezoo Gowhari Shabgah Breakdown of academic impact, for papers by Duen-Yi Huang Breakdown of academic impact, for papers by Javier Megías Breakdown of academic impact, for papers by Xueming Zhang Breakdown of academic impact, for papers by Vincenzo Flati Breakdown of academic impact, for papers by Chen Shao Breakdown of academic impact, for papers by Dexi Zhou Breakdown of academic impact, for papers by Xianghong Xu
Rankless by CCL
2026